Clinical Trials Browser

Phase 2 × Bile Duct Neoplasms × cabozantinib × Clear all

NCT01954745 2017-02-03

Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma

Phase 2 Completed

19 enrolled 8 charts

Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma